These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6776543)

  • 61. Effects of acute administration of mazindol on brain energy metabolism in adult mice.
    Gonçalves CL; Scaini G; Rezin GT; Jeremias IC; Bez GD; Daufenbach JF; Gomes LM; Ferreira GK; Zugno AI; Streck EL
    Acta Neuropsychiatr; 2014 Jun; 26(3):146-54. PubMed ID: 25142190
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of mazindol on dystrophic mice and on growth in young rats.
    Coakley JH; Jackson MJ; Wagenmakers AJ; Ensor D; Edwards RH
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 92(2):385-9. PubMed ID: 2565192
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [New enzymatic and endocrinological aspects in two cases of Werner's syndrome (author's transl)].
    Corrales Hernández JJ; Miralles García JM; Rodríguez Commes JL; Martín Vasallo P; García Vasallo P; de Pablo Dávila F
    Med Clin (Barc); 1980 May; 74(9):355-64. PubMed ID: 6247588
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of an anorectic agent, AN 448 on weight reduction and plasma lipids.
    Ishikawa T; Nakaya N; Nakamura H; Goto Y
    Keio J Med; 1975 Jul; 24(3):211-8. PubMed ID: 1219154
    [No Abstract]   [Full Text] [Related]  

  • 65. [Mazindol (Teronac) in the treatment of predominant by food-dependent obesity].
    Husmann F
    Med Welt; 1976 Oct; 27(40):1904-8. PubMed ID: 790077
    [No Abstract]   [Full Text] [Related]  

  • 66. [Mazindol in the treatment of obesity in diabetics (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1977 Sep; 116(39):1214-7. PubMed ID: 922789
    [No Abstract]   [Full Text] [Related]  

  • 67. [Effect of mazindol on glucose absorption in everted rat small intestine].
    Tsuchiya M; Inoue S; Satta M; Yoshimura H; Arita M; Takamura Y
    Nihon Yakurigaku Zasshi; 1986 Jun; 87(6):649-54. PubMed ID: 3744170
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effect of eating and mazindol on the pain threshold in obese and lean persons].
    Zahorska-Markiewicz B; Kucio C
    Pol Arch Med Wewn; 1985 Sep; 74(3):203-6. PubMed ID: 3880320
    [No Abstract]   [Full Text] [Related]  

  • 69. A multi-centre trial of mazindol ('Teronac') in general practice in Ireland.
    Evans ER; Wallace MG
    Curr Med Res Opin; 1975; 3(3):132-7. PubMed ID: 1149481
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Increased somatotrophin response to insulin induced hypoglycemia with D-amphetamine treatment (author's transl)].
    Malacara JM; de los Angeles Camarena M; López MA; Gómez E
    Rev Invest Clin; 1978; 30(2):109-14. PubMed ID: 674916
    [No Abstract]   [Full Text] [Related]  

  • 71. Effect of mazindol on glucose uptake into human isolated skeletal muscle.
    Kirby MJ; Turner P
    J Pharm Pharmacol; 1976 Feb; 28(2):163-4. PubMed ID: 6681
    [No Abstract]   [Full Text] [Related]  

  • 72. [Drug therapy in obesity].
    Ishii J
    Nihon Rinsho; 1988 Nov; 46(11):2491-6. PubMed ID: 3241376
    [No Abstract]   [Full Text] [Related]  

  • 73. [Evaluation of the effect of mazindol on the metabolism and lipolysis in obese women].
    Kucio C; Zahorska-Markiewicz B; Piskorska D; Semenowicz-Siuda K; Waluga M
    Pol Arch Med Wewn; 1987 Mar; 77(3):73-6. PubMed ID: 3275392
    [No Abstract]   [Full Text] [Related]  

  • 74. Chemistry and pharmacology of mazindol.
    Gogerty JH; Trafold JH
    Triangle; 1976; 15(1):25-36. PubMed ID: 960214
    [No Abstract]   [Full Text] [Related]  

  • 75. [Analysis and biotransformation of mazindol (Teronac) a new anti-obesity drug].
    Ebel S; Schütz H
    Arch Kriminol; 1977; 160(3-4):78-86. PubMed ID: 931504
    [No Abstract]   [Full Text] [Related]  

  • 76. [Hormone content of the blood serum determinable by a radioimmune method in chronic pyoderma patients].
    Bukharovich AM; Litvin AA
    Vestn Dermatol Venerol; 1984 Jul; (7):12-6. PubMed ID: 6475272
    [No Abstract]   [Full Text] [Related]  

  • 77. [Changes in the plasma levels of immunoreactive insulin during treatment of obesity with thyroid preparations].
    Dolecek R; Závada M; Beska F
    Cas Lek Cesk; 1972 Feb; 111(7):160-2. PubMed ID: 5010323
    [No Abstract]   [Full Text] [Related]  

  • 78. [Overweight as a therapeutic problem. Experience with the appetite depressant Mazindol].
    Linke H
    Med Welt; 1976 Oct; 27(42):2021-5. PubMed ID: 792620
    [No Abstract]   [Full Text] [Related]  

  • 79. Drug preference and mood in humans: mazindol and phenylpropanolamine.
    Chait LD; Uhlenhuth EH; Johanson CE
    NIDA Res Monogr; 1984 Mar; 49():327-8. PubMed ID: 6434978
    [No Abstract]   [Full Text] [Related]  

  • 80. Aphrodisia with mazindol.
    Friesen LV
    Lancet; 1976 Oct; 2(7992):974. PubMed ID: 62210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.